Influenza :: Trivalent inactivated influenza vaccine in children is safe

Beginning with the winter season of 2004-2005, influenza vaccination has been recommended for all children 6 to 23 months old in the United States. However, its safety in young children has not been adequately studied in large populations. A study was conducted by Simon J. Hambidge to screen for medically attended events in the clinic, emergency department, or hospital after administration of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Health :: Testosterone – more than a virility hormone, stops aging

Testosterone apparently is not just a virility hormone. It also helps older men keep their balance and avoid falls. According to a new study from Oregon Health & Science University, older men with low testosterone are much more prone to falling. The study, published in the American Medical Association journal “Archives of Internal Medicine”, strengthens the link between levels of the naturally produced male hormone and the health of men 65 years and older.

Cancer :: Select chemotherapy in cancer patients after genomic test

Scientists at Duke University’s Institute for Genome Sciences & Policy have developed a panel of genomic tests that analyzes the unique molecular traits of a cancerous tumor and determines, which chemotherapy will most aggressively attack that patient’s cancer.

Fertility :: Increased risk of infertility on using mobile phones

Men who use mobile phones could be risking their fertility, warn researchers. A new study shows a worrying link between poor sperm and the number of hours a day that a man uses his mobile phone. Those who made calls on a mobile phone for more than four hours a day had the worst sperm counts and the poorest quality sperm, according to results released at the American Society for Reproductive Medicine annual meeting in New Orleans. Doctors believe the damage could be caused by the electromagnetic radiation emitted by handsets or the heat they generate.

Tennis Elbow :: New biologic treatment for tennis elbow may replace surgery

A person suffering from tennis elbow may not have to look any further than his or her own body for the most effective treatment, according to a study published in the November issue of The American Journal of Sports Medicine. Specially prepared platelets taken from the patient which are then re-injected into the tendon of the affected elbow provides more relief than more commonly-used therapies which have failed to yield results, often resulting in surgery, concludes study authors Allan Mishra MD and Terri Pavelko, PAC, PT, of the Menlo Medical Clinic, Stanford University Medical Center, Menlo Park, Calif.

Health :: Glivec, imatinib approved for five rare life threatening disorders

In another important milestone, Glivec? (imatinib) has received US regulatory approval to help patients with five distinct and potentially life-threatening disorders, representing the first time that a regulatory authority has ever simultaneously approved one targeted medicine for so many disorders. With today’s decision, and in only five years, Glivec has now been approved in the US for seven diseases, including two solid tumors and five blood disorders with molecular targets known to be inhibited by the drug.

Heart Disease :: GlaxoSmithKline’s COREG, carvedilol phosphate for cardiovascular conditions

GlaxoSmithKline (NYSE: GSK) and Flamel Technologies (NASDAQ:FLML) announced FDA approval of once-a-day Coreg CR (carvedilol phosphate) extended-release capsules, for the treatment of three cardiovascular conditions: 1. High blood pressure, also known as hypertension. 2. A heart attack that has reduced how well the heart pumps (known medically as post-myocardial infarction left ventricular dysfunction). 3. Mild to severe heart failure.

HIV :: REYATAZ, atazanavir sulfate for Adults With HIV-1 Infection

Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted approval of a new 300 mg single capsule formulation of REYATAZ? (atazanavir sulfate) for the treatment of HIV-1 infection in adults as part of combination therapy. Taken once daily along with ritonavir and food as part of a anti-HIV drug regimen, the REYATAZ 300 mg single capsule formulation can replace two REYATAZ 150 mg capsules for: patients who have previously received anti-HIV medicines, patients who will be receiving tenofovir disoproxil fumarate, and patients who have never taken anti-HIV medicines that require SUSTIVA? (efavirenz) as part of their anti-HIV drug regimen. The REYATAZ single capsule formulation will be available in the United States within seven business days.

Hypertension :: Positive emotions linked to lower blood pressure

Having a positive outlook makes life more enjoyable, and it may also lower blood pressure in older adults. Among more than 2,500 people aged 65 or older, the higher a person scored on a questionnaire measuring positive emotions, the lower was his or her blood pressure. “Our thoughts and emotions do affect our physical processes,” Dr. Glenn V. Ostir of the University of Texas Medical Branch in Galveston, the study’s lead author, told. “The nice thing is that we have some control over that.”

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack